Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies

Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies

The enzyme reverse transcriptase (RT) plays a central role in the life cycle of human immunodeficiency virus (HIV), and RT has been an important drug target. Elucidations of the RT structures trapping and detailing the enzyme at various functional and conformational states by X-ray crystallography h...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Abhimanyu K. Singh, Kalyan Das
التنسيق:	مقال
اللغة:	English
منشور في:	MDPI AG 2022-05-01
سلاسل:	Viruses
الموضوعات:	HIV-RT NRTI NNRTI drug design structural biology crystallography
الوصول للمادة أونلاين:	https://www.mdpi.com/1999-4915/14/5/1027

مواد مشابهة

Approved HIV reverse transcriptase inhibitors in the past decade
حسب: Guangdi Li, وآخرون
منشور في: (2022-04-01)

Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV
حسب: Sara Iannuzzi, وآخرون
منشور في: (2021-07-01)

The “Connection” Between HIV Drug Resistance and RNase H
حسب: Krista A. Delviks-Frankenberry, وآخرون
منشور في: (2010-07-01)

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV
حسب: Oliver T. Stirrup, وآخرون
منشور في: (2019-10-01)

Development of HIV Drug Resistance in a Cohort of Adults on First-Line Antiretroviral Therapy in Tanzania during the Stavudine Era
حسب: Raphael Z. Sangeda, وآخرون
منشور في: (2021-11-01)

Identification of a 3-aminoimidazo[1,2-a]pyridine inhibitor of HIV-1 reverse transcriptase
حسب: Elleder Daniel, وآخرون
منشور في: (2012-12-01)

Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
حسب: A. V. Kravchenko, وآخرون
منشور في: (2018-07-01)

Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility
حسب: Tomasz Frączek, وآخرون
منشور في: (2018-01-01)

APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants
حسب: Richa Dwivedi, وآخرون
منشور في: (2022-07-01)

Incidence and risk factors for neuropsychiatric events among Ghanaian HIV patients on long-term non-nucleoside reverse transcriptase inhibitor-based therapy
حسب: Fred S. Sarfo, وآخرون
منشور في: (2016-06-01)

Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
حسب: Nicolas Sluis-Cremer, وآخرون
منشور في: (2013-11-01)

Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy
حسب: Eriko Ohsaki, وآخرون
منشور في: (2021-08-01)

Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability
حسب: Ya-Li Sang, وآخرون
منشور في: (2023-07-01)

The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study
حسب: Orasri Wittawatmongkol, وآخرون
منشور في: (2015-07-01)

Development of fluorine-substituted NH2-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability
حسب: Xin Jin, وآخرون
منشور في: (2023-03-01)

Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir
حسب: Hyeonah Byun, وآخرون
منشور في: (2024-12-01)

Anti‐HIV drugs reduce risk of prediabetes and progression to type 2 diabetes in HIV‐infected patients
حسب: Joseph Magagnoli, وآخرون
منشور في: (2023-06-01)

Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
حسب: Ting-Ting Li, وآخرون
منشور في: (2020-03-01)

Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport
حسب: John Haynes, وآخرون
منشور في: (2024-12-01)

The Lysine 65 Residue in HIV-1 Reverse Transcriptase Function and in Nucleoside Analog Drug Resistance
حسب: Scott J. Garforth, وآخرون
منشور في: (2014-10-01)

Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
حسب: Stefan G. Sarafianos, وآخرون
منشور في: (2010-02-01)

Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors
حسب: Kamalendra Singh, وآخرون
منشور في: (2014-09-01)

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data
حسب: Oliver T. Stirrup, وآخرون
منشور في: (2018-04-01)

Evaluation of the HIV-1 drug resistance to elsulfavirine and the effectiveness of it among Russian treatment-naïve patients
حسب: A. A. Kirichenko, وآخرون
منشور في: (2021-01-01)

Global Conformational Dynamics of HIV-1 Reverse Transcriptase Bound to Non-Nucleoside Inhibitors
حسب: Peter V. Coveney, وآخرون
منشور في: (2012-07-01)

Drosophila model of anti-retroviral therapy induced peripheral neuropathy and nociceptive hypersensitivity
حسب: Keegan M. Bush, وآخرون
منشور في: (2021-01-01)

Nucleoside Analog 2′,3′-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1
حسب: Ksenia Glumakova, وآخرون
منشور في: (2023-09-01)

NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal
حسب: Benjamin Trinité, وآخرون
منشور في: (2019-06-01)

HIV drug resistance prediction with weighted categorical kernel functions
حسب: Elies Ramon, وآخرون
منشور في: (2019-07-01)

HIV medication to prevent fetal infection during pregnancy
حسب: Teodora Gabriela Cioroba, وآخرون
منشور في: (2022-03-01)

High frequency of Lamivudine and Telbivudine resistance mutations in hepatitis B virus isolates from human immunodeficiency virus co-infected patients on highly active antiretroviral therapy in Bucaramanga, Colombia
حسب: Henry Bautista-Amorocho, وآخرون
منشور في: (2023-07-01)

Anthrarufin and Its Anionic Moieties as Potential Inhibitors of HIV-1 Reverse Transcriptase (RT)
حسب: Svetlana Jeremić, وآخرون
منشور في: (2022-11-01)

K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine
حسب: Nikita Reddy, وآخرون
منشور في: (2024-09-01)

Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation
حسب: Aanand Sonawane, وآخرون
منشور في: (2024-11-01)

Machine learning aided multiscale modelling of the HIV-1 infection in the presence of NRTI therapy
حسب: Huseyin Tunc, وآخرون
منشور في: (2023-03-01)

Targeting the Structural Maturation Pathway of HIV-1 Reverse Transcriptase
حسب: Thomas W. Kirby, وآخرون
منشور في: (2023-11-01)

The Molecular Docking of Specific Reverse Transcriptase Inhibitory Ligands onto the Molecular Model of HIV-1 Reverse Transcriptase
حسب: Roohallah Yousefi
منشور في: (2024-06-01)

Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz
حسب: Maryam A. Jordaan, وآخرون
منشور في: (2020-08-01)

Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection
حسب: Dongwei Kang, وآخرون
منشور في: (2022-10-01)

Transmitted drug resistance to rilpivirine among antiretroviral‐naïve patients living with HIV from northern Poland
حسب: Miłosz Parczewski, وآخرون
منشور في: (2014-01-01)